300 related articles for article (PubMed ID: 23980144)
1. Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity.
Benjamin DI; Cozzo A; Ji X; Roberts LS; Louie SM; Mulvihill MM; Luo K; Nomura DK
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14912-7. PubMed ID: 23980144
[TBL] [Abstract][Full Text] [Related]
2. Alkylglyceronephosphate synthase (AGPS) alters lipid signaling pathways and supports chemotherapy resistance of glioma and hepatic carcinoma cell lines.
Zhu Y; Liu XJ; Yang P; Zhao M; Lv LX; Zhang GD; Wang Q; Zhang L
Asian Pac J Cancer Prev; 2014; 15(7):3219-26. PubMed ID: 24815474
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Inhibitors for the Ether Lipid-Generating Enzyme AGPS as Anti-Cancer Agents.
Piano V; Benjamin DI; Valente S; Nenci S; Marrocco B; Mai A; Aliverti A; Nomura DK; Mattevi A
ACS Chem Biol; 2015 Nov; 10(11):2589-97. PubMed ID: 26322624
[TBL] [Abstract][Full Text] [Related]
4. Development of alkyl glycerone phosphate synthase inhibitors: Structure-activity relationship and effects on ether lipids and epithelial-mesenchymal transition in cancer cells.
Stazi G; Battistelli C; Piano V; Mazzone R; Marrocco B; Marchese S; Louie SM; Zwergel C; Antonini L; Patsilinakos A; Ragno R; Viviano M; Sbardella G; Ciogli A; Fabrizi G; Cirilli R; Strippoli R; Marchetti A; Tripodi M; Nomura DK; Mattevi A; Mai A; Valente S
Eur J Med Chem; 2019 Feb; 163():722-735. PubMed ID: 30576903
[TBL] [Abstract][Full Text] [Related]
5. Role and mechanism of the alkylglycerone phosphate synthase in suppressing the invasion potential of human glioma and hepatic carcinoma cells in vitro.
Zhu Y; Zhu L; Lu L; Zhang L; Zhang G; Wang Q; Yang P
Oncol Rep; 2014 Jul; 32(1):431-6. PubMed ID: 24841318
[TBL] [Abstract][Full Text] [Related]
6. Mass Spectrometry and Computer Simulation Predict the Interactions of AGPS and HNRNPK in Glioma.
Zhou W; Liu Y; Li H; Song Z; Ma Y; Zhu Y
Biomed Res Int; 2021; 2021():6181936. PubMed ID: 34621897
[TBL] [Abstract][Full Text] [Related]
7. Cancer cells incorporate and remodel exogenous palmitate into structural and oncogenic signaling lipids.
Louie SM; Roberts LS; Mulvihill MM; Luo K; Nomura DK
Biochim Biophys Acta; 2013 Oct; 1831(10):1566-72. PubMed ID: 23872477
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of isothiocyanate derivant targeting AGPS by computer-aid drug design on proliferation of glioma and hepatic carcinoma cells.
Zhu Y; Li WM; Zhang L; Xue J; Zhao M; Yang P
Int J Clin Exp Pathol; 2015; 8(1):812-7. PubMed ID: 25755779
[TBL] [Abstract][Full Text] [Related]
9. Blind sterile 2 (bs2), a hypomorphic mutation in Agps, results in cataracts and male sterility in mice.
Liegel R; Chang B; Dubielzig R; Sidjanin DJ
Mol Genet Metab; 2011 May; 103(1):51-9. PubMed ID: 21353609
[TBL] [Abstract][Full Text] [Related]
10. Aberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling.
Ray U; Roy SS
FEBS J; 2018 Feb; 285(3):432-443. PubMed ID: 28971574
[TBL] [Abstract][Full Text] [Related]
11. Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer.
Snaebjornsson MT; Janaki-Raman S; Schulze A
Cell Metab; 2020 Jan; 31(1):62-76. PubMed ID: 31813823
[TBL] [Abstract][Full Text] [Related]
12. Effect of SCP-x gene ablation on branched-chain fatty acid metabolism.
Atshaves BP; McIntosh AL; Landrock D; Payne HR; Mackie JT; Maeda N; Ball J; Schroeder F; Kier AB
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G939-51. PubMed ID: 17068117
[TBL] [Abstract][Full Text] [Related]
13. Inositol phosphate recycling regulates glycolytic and lipid metabolism that drives cancer aggressiveness.
Benjamin DI; Louie SM; Mulvihill MM; Kohnz RA; Li DS; Chan LG; Sorrentino A; Bandyopadhyay S; Cozzo A; Ohiri A; Goga A; Ng SW; Nomura DK
ACS Chem Biol; 2014 Jun; 9(6):1340-50. PubMed ID: 24738946
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid synthase plays a role in cancer metabolism beyond providing fatty acids for phospholipid synthesis or sustaining elevations in glycolytic activity.
Hopperton KE; Duncan RE; Bazinet RP; Archer MC
Exp Cell Res; 2014 Jan; 320(2):302-10. PubMed ID: 24200503
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of fatty alcohol in MCF-7 breast cancer cells.
Welsh CJ; Robinson M; Warne TR; Pierce JH; Yeh GC; Phang JM
Arch Biochem Biophys; 1994 Nov; 315(1):41-7. PubMed ID: 7979403
[TBL] [Abstract][Full Text] [Related]
16. Ether--lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether--lipid analogues in Leishmania.
Lux H; Heise N; Klenner T; Hart D; Opperdoes FR
Mol Biochem Parasitol; 2000 Nov; 111(1):1-14. PubMed ID: 11087912
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs.
Murray M; Hraiki A; Bebawy M; Pazderka C; Rawling T
Pharmacol Ther; 2015 Jun; 150():109-28. PubMed ID: 25603423
[TBL] [Abstract][Full Text] [Related]
18. Peroxisomes: a nexus for lipid metabolism and cellular signaling.
Lodhi IJ; Semenkovich CF
Cell Metab; 2014 Mar; 19(3):380-92. PubMed ID: 24508507
[TBL] [Abstract][Full Text] [Related]
19. NDRG1 regulates neutral lipid metabolism in breast cancer cells.
Sevinsky CJ; Khan F; Kokabee L; Darehshouri A; Maddipati KR; Conklin DS
Breast Cancer Res; 2018 Jun; 20(1):55. PubMed ID: 29898756
[TBL] [Abstract][Full Text] [Related]
20. Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy.
Jaffrès PA; Gajate C; Bouchet AM; Couthon-Gourvès H; Chantôme A; Potier-Cartereau M; Besson P; Bougnoux P; Mollinedo F; Vandier C
Pharmacol Ther; 2016 Sep; 165():114-31. PubMed ID: 27288726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
